Govt may cut interest rate on PPF, NSC, Senior Citizen Saving Scheme & Sukanya Samriddhi Yojana

The government official sees scope for a 50 bps repo rate cut

Moneycontrol News

March 11, 2020 / 14:16 IST

The government is likely to reduce the interest rate on small savings schemes, a senior government official told CNBC-TV18.

This move is likely to affect interest rates of Public Provident Fund (PPF), National Savings Certificate (NSC), Senior Citizen Saving Scheme (SCSS) Sukanya Samriddhi Yojana (SSY) and other small savings schemes.

"The gap between the repo rate and the small savings rate needs to come down. Small savings rates are likely to be reduced," a government official told the channel.

Moneycontrol could not independently verify the report.

Wading into the debate on whether the Reserve Bank of India (RBI) should cut policy rates to stem the economic slowdown after the US Federal Reserve, Bank of England and other prominent central banks announced a similar cut, the official said, "There is scope to cut repo rates by 50 bps. The Reserve Bank may reduce its policy rate by 25 bps. The repo rate should ideally be reduced between two Monetary Policy Committee (MPC) meets," the official added. (100 bps=1 percentage point)

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show